{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:20:58Z","timestamp":1782624058860,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.breast.2015.07.013","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T21:03:37Z","timestamp":1446843817000},"page":"S51-S55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S2","title":["Impact of preventive therapy on the risk of breast cancer among women with benign breast disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Jack","family":"Cuzick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Sestak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh A.","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.breast.2015.07.013_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.breast.2015.07.013_bib2","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","article-title":"Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data","volume":"23","author":"Chuba","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2015.07.013_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<392::AID-IJC14>3.0.CO;2-A","article-title":"Second cancers following in situ carcinoma of the breast","volume":"77","author":"Franceschi","year":"1998","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.breast.2015.07.013_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","article-title":"Lobular neoplasia (so-called lobular carcinoma in situ) of the breast","volume":"42","author":"Haagensen","year":"1978","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.breast.2015.07.013_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0277-5379(91)90055-I","article-title":"Risk of invasive cancer in women with lobular carcinoma in situ of the breast","volume":"27","author":"Salvadori","year":"1991","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.breast.2015.07.013_bib6","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","article-title":"Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease","volume":"22","author":"Page","year":"1991","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.breast.2015.07.013_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000478-197809000-00001","article-title":"Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years","volume":"2","author":"Rosen","year":"1978","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.breast.2015.07.013_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast\u2013risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.breast.2015.07.013_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncr.22408","article-title":"Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study","volume":"109","author":"Collins","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.breast.2015.07.013_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","article-title":"Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study","volume":"7","author":"Hartmann","year":"2014","journal-title":"Cancer Prev Res"},{"issue":"3","key":"10.1016\/j.breast.2015.07.013_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.breast.2015.07.013_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0960-9776(03)00123-1","article-title":"Systematic review of fibroadenoma as a risk factor for breast cancer","volume":"12","author":"El-Wakeel","year":"2003","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.breast.2015.07.013_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1008263522021","article-title":"Risk of breast cancer subsequent to histological or clinical diagnosis of fibroadenoma\u2013retrospective longitudinal study of 3938 cases","volume":"8","author":"Ciatto","year":"1997","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"1","key":"10.1016\/j.breast.2015.07.013_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM199407073310103","article-title":"Long-term risk of breast cancer in women with fibroadenoma","volume":"331","author":"Dupont","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.breast.2015.07.013_bib15","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C","article-title":"Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group","volume":"69","author":"McDivitt","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2015.07.013_bib16","series-title":"Breast carcinoma: risk and detection","author":"Haagensen","year":"1981"},{"issue":"2","key":"10.1016\/j.breast.2015.07.013_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10549-005-9110-y","article-title":"Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies","volume":"97","author":"Mannello","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"9166","key":"10.1016\/j.breast.2015.07.013_bib18","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(98)06408-3","article-title":"Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group","volume":"353","author":"Dixon","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.breast.2015.07.013_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/bjc.1991.433","article-title":"Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?","volume":"64","author":"Bundred","year":"1991","journal-title":"Br J Cancer"},{"issue":"18","key":"10.1016\/j.breast.2015.07.013_bib20","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9336","key":"10.1016\/j.breast.2015.07.013_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","article-title":"First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial","volume":"360","author":"Cuzick","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.breast.2015.07.013_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","article-title":"Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial","volume":"16","author":"Cuzick","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9922","key":"10.1016\/j.breast.2015.07.013_bib23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.breast.2015.07.013_bib24","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2015.07.013_bib25","series-title":"Pathology and genetics of tumours of the breast and female genital organs","first-page":"63","article-title":"Intraductal proliferative lesions","author":"Tavassoli","year":"2003"},{"issue":"14","key":"10.1016\/j.breast.2015.07.013_bib26","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0959-8049(00)00181-7","article-title":"Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology","volume":"36","author":"Elston","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2015.07.013_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1746-1596-9-121","article-title":"Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast","volume":"9","author":"Gomes","year":"2014","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1016\/j.breast.2015.07.013_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/modpathol.2011.66","article-title":"Atypical ductal hyperplasia: interobserver and intraobserver variability","volume":"24","author":"Jain","year":"2011","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.breast.2015.07.013_bib29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00000478-199212000-00001","article-title":"Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria","volume":"16","author":"Schnitt","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.breast.2015.07.013_bib30","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/0959-8049(94)00261-3","article-title":"Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology","volume":"30A","author":"Sloane","year":"1994","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.breast.2015.07.013_bib31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.breast.2015.07.013_bib32","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.breast.2015.07.013_bib33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"issue":"22","key":"10.1016\/j.breast.2015.07.013_bib34","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","article-title":"Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia","volume":"28","author":"Boughey","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"33","key":"10.1016\/j.breast.2015.07.013_bib35","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1200\/JCO.2007.14.8833","article-title":"Assessment of the accuracy of the Gail model in women with atypical hyperplasia","volume":"26","author":"Pankratz","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2015.07.013_bib36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10549-012-2089-2","article-title":"Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010","volume":"134","author":"Waters","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2015.07.013_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ypmed.2004.09.041","article-title":"Factors affecting breast cancer risk reduction practices among California physicians","volume":"41","author":"Kaplan","year":"2005","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/j.breast.2015.07.013_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1370\/afm.284","article-title":"Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump","volume":"3","author":"Taylor","year":"2005","journal-title":"Ann Fam Med"},{"issue":"7","key":"10.1016\/j.breast.2015.07.013_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s10434-001-0580-9","article-title":"Patient reluctance toward tamoxifen use for breast cancer primary prevention","volume":"8","author":"Port","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2015.07.013_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1524-4741.2007.00388.x","article-title":"Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population","volume":"13","author":"Worsham","year":"2007","journal-title":"Breast J"},{"issue":"6","key":"10.1016\/j.breast.2015.07.013_bib41","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/cncr.22136","article-title":"The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study","volume":"107","author":"Collins","year":"2006","journal-title":"Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977615001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977615001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:33:42Z","timestamp":1760776422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977615001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":41,"alternative-id":["S0960977615001514"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2015.07.013","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of preventive therapy on the risk of breast cancer among women with benign breast disease","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2015.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}